Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Apr 23, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to gather information and samples from patients with various skin diseases that are caused by problems with the immune system, such as autoimmune bullous dermatosis, psoriasis, and eczema. The goal is to collect clinical data and biological samples to help researchers identify new markers that can lead to better treatments for these conditions. This study is currently recruiting participants, which means they are looking for people to join.

To be eligible for this trial, individuals must have skin damage that is likely due to an autoimmune, dysimmune (related to immune system dysfunction), or auto-inflammatory issue. This includes adults and children with conditions like pemphigus, lupus, and other related skin diseases. However, children under 6 years old and pregnant or breastfeeding women cannot participate. If you join the study, you can expect to provide samples and information that may help improve understanding and treatment of these skin diseases in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin.
• The patients included may be adults or children, and will be:
• • Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),
• • Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),
• • Patients with cutaneous lupus
• • Patients with dysimmune skin diseases (psoriasis, eczema)
• • Patients with immuno-induced dermatological disorders or drug dermatitis
• • Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.).
• • Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected
• Exclusion Criteria:
• • Patients under protective supervision (guardianship, curators)
• • Patients under 6 years old
• • Pregnant or breastfeeding woman